Abstract
Indications for AICD implantation include previous history of monomorphic or polymorphic ventricular tachycardia (VT) or ventricular fibrillation (VF) resulting in cardiac arrest or syncope and sustained VT with structural heart disease and cardiomyopathy with low ejection fraction, as this is a significant risk factor for developing VT (Epstein et al., Circulation. 117:e350–408, 2008). Approximately 50–75% of AICD discharges result from an appropriate device response to a malignant ventricular arrhythmia, either VT of VF. More than 30% of patients with a history of VT or VF experience an appropriate AICD discharge for a malignant ventricular dysrhythmia within the initial 2 years of AICD implantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350–408. https://doi.org/10.1161/CIRCUALTIONAHA.108.189742.
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75. https://doi.org/10.1016/j.jacc.2012.11.007.
Liu CP, Ho YL, Lin YH, Liu YB, Chang WT, Huang CH, et al. Management of patients with implantable cardioverter defibrillators at emergency departments. Emerg Med J. 2007;24(2):106–9. https://doi.org/10.1136/emj.2006.037788.
Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation. 2004;110(17):2591–6. https://doi.org/10.1161/01.CIR.0000145610.64014.E4.
Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. 2003;14(9):940–8.
Dichtl W, Wolber T, Paoli U, Brullmann S, Stuhlinger M, Berger T, et al. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol. 2011;34(7):433–6. https://doi.org/10.1002/clc.20910.
Iftikhar S, Mattu A, Brady W. ED evaluation and management of implantable cardiac defibrillator electrical shocks. Am J Emerg Med. 2016;34(6):1140–7. https://doi.org/10.1016/j.ajem.2016.02.060.
Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology. Circulation. 1996;94(5):1147–66.
Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE, Gross WL, Hayes DL, et al. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation. 2004;110(25):3866–9. https://doi.org/10.1161/01.CIR.0000149716.03295.7C.
Akhtar M, Bhat T, Tantray M, Lafferty C, Faisal S, Teli S, et al. Electromagnetic interference with implantable cardioverter defibrillators causing inadvertent shock: case report and review of current literature. Clin Med Insights Cardiol. 2014;8:63–6. https://doi.org/10.4137/CMC.S10990.
Disclosure Statement
The authors of this chapter report no significant disclosures.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Malone, M., Panchal, A. (2020). Defibrillator Malfunction: It’s Electric! Boogie, Woogie, Woogie! . In: Kaide, C., San Miguel, C. (eds) Case Studies in Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-22445-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-22445-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22444-8
Online ISBN: 978-3-030-22445-5
eBook Packages: MedicineMedicine (R0)